文献速递消化系统肿瘤支持与姑息治疗

预测接受结直肠癌手术的老年患者功能恢复与生活质量:国际GOSAFE研究的真实世界数据

Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.
PubMed 文献 · J Clin Oncol · 2023-06-30

GOSAFE研究前瞻性纳入70岁及以上接受择期结直肠癌大手术的患者,评估未能达到良好生活质量和功能恢复的风险因素。625例患者中,术后3-6个月多数生活质量良好或改善,功能恢复在结肠癌为78.6%、直肠癌为70.6%。术前筛查工具评分≥2、术后并发症、ECOG体能状态≥2、Charlson年龄共病指数≥7、严重并发症和姑息性手术是未能达到这些结局的预测因素。

要点

  • 多数老年结直肠癌患者术后3-6个月生活质量良好或改善,功能恢复率结肠癌78.6%、直肠癌70.6%。
  • 术前fTRST≥2和术后并发症与结肠癌切除术后生活质量下降相关。
  • ECOG PS≥2是直肠癌亚组术后生活质量下降的强预测因素。

核心结论

  • 多数老年患者在接受结直肠癌手术后生活质量良好并保持独立。
  • 现已确定未能达到这些重要结局的预测因素,可用于指导患者和家属的术前咨询。

研究设计与样本

  • GOSAFE研究为前瞻性研究,纳入70岁及以上接受择期结直肠癌大手术的患者,进行衰弱评估并记录术后3个月和6个月的生活质量(EQ-5D-3L)。
  • 共625/646例连续患者(96.9%)有前瞻性完整数据,其中结肠癌435例、直肠癌190例;男性占52.6%,中位年龄79.0岁(IQR 74.6-82.9岁)。
  • 手术方式为微创手术的患者占73%(结肠癌321/435例;直肠癌135/190例)。
  • 术后功能恢复定义为日常生活活动能力评分≥5分、计时起立行走测试<20秒和MiniCog>2分三项的组合。

主要发现

  • 术后3-6个月,68.9%-70.3%的患者生活质量相等或更好(结肠癌72.8%-72.9%,直肠癌60.1%-63.9%)。
  • 在结肠癌切除术后生活质量下降的logistic回归分析中,术前Flemish分诊风险筛查工具(fTRST)≥2的3个月OR为1.68(95%CI 1.04-2.73,P=0.034)、6个月OR为1.71(95%CI 1.06-2.75,P=0.027);术后并发症的3个月OR为2.03(95%CI 1.20-3.42,P=0.008)、6个月OR为2.56(95%CI 1.15-5.68,P=0.02)。
  • 在直肠癌亚组中,ECOG体能状态(ECOG PS)≥2是术后生活质量下降的强预测因素(OR 3.81,95%CI 1.45-9.92,P=0.006)。
  • 功能恢复在结肠癌患者中为254/323例(78.6%),在直肠癌患者中为94/133例(70.6%)。
  • 未能达到功能恢复的风险因素包括:Charlson年龄共病指数≥7(OR 2.59,95%CI 1.26-5.32,P=0.009)、ECOG≥2(结肠癌OR 3.12,95%CI 1.36-7.20,P=0.007;直肠癌OR 4.61,95%CI 1.45-14.63,P=0.009)、严重并发症(OR 17.33,95%CI 7.30-40.8,P<0.001)、fTRST≥2(OR 2.71,95%CI 1.40-5.25,P=0.003)和姑息性手术(OR 4.11,95%CI 1.29-13.07,P=0.017)。

关键数值与推荐

  • 术后功能恢复定义:日常生活活动能力≥5分、计时起立行走测试<20秒和MiniCog>2分三项的组合。
  • 生活质量采用EQ-5D-3L工具在术后3个月和6个月记录。
  • 术前衰弱评估包括Flemish分诊风险筛查工具(fTRST)、Charlson年龄共病指数和ECOG体能状态。

临床怎么用

  • 原文结论指出,已确定的预测因素可用于指导患者和家属的术前咨询。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The GOSAFE study evaluates risk factors for failing to achieve good quality of life (QoL) and functional recovery (FR) in older patients undergoing surgery for colon and rectal cancer. METHODS: Patients age 70 years and older undergoing major elective colorectal surgery were prospectively enrolled. Frailty assessment was performed and outcomes, including QoL (EQ-5D-3L) recorded (3/6 months postoperatively). Postoperative FR was defined as a combination of Activity of Daily Living ≥5 + Timed Up & Go test <20 seconds + MiniCog >2. RESULTS: Prospective complete data were available for 625/646 consecutive patients (96.9%; 435 colon and 190 rectal cancer), 52.6% men, and median age was 79.0 years (IQR, 74.6-82.9 years). Surgery was minimally invasive in 73% of patients (321/435 colon; 135/190 rectum). At 3-6 months, 68.9%-70.3% patients experienced equal/better QoL (72.8%-72.9% colon, 60.1%-63.9% rectal cancer). At logistic regression analysis, preoperative Flemish Triage Risk Screening Tool ≥2 (3-month odds ratio [OR], 1.68; 95% CI, 1.04 to 2.73; P = .034, 6-month OR, 1.71; 95% CI, 1.06 to 2.75; P = .027) and postoperative complications (3-month OR, 2.03; 95% CI, 1.20 to 3.42; P = .008, 6-month OR, 2.56; 95% CI, 1.15 to 5.68; P = .02) are associated with decreased QoL after colectomy. Eastern Collaborative Oncology Group performance status (ECOG PS) ≥2 is a strong predictor of postoperative QoL decline in the rectal cancer subgroup (OR, 3.81; 95% CI, 1.45 to 9.92; P = .006). FR was reported by 254/323 (78.6%) patients with colon and 94/133 (70.6%) with rectal cancer. Charlson Age Comorbidity Index ≥7 (OR, 2.59; 95% CI, 1.26 to 5.32; P = .009), ECOG ≥2 (OR, 3.12; 95% CI, 1.36 to 7.20; P = .007 colon; OR, 4.61; 95% CI, 1.45 to 14.63; P = .009 rectal surgery), severe complications (OR, 17.33; 95% CI, 7.30 to 40.8; P < .001), fTRST ≥2 (OR, 2.71; 95% CI, 1.40 to 5.25; P = .003), and palliative surgery (OR, 4.11; 95% CI, 1.29 to 13.07; P = .017) are risk factors for not achieving FR. CONCLUSION: The majority of older patients experience good QoL and stay independent after colorectal cancer surgery. Predictors for failing to achieve these essential outcomes are now defined to guide patients' and families' preoperative counseling.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Montroni I, Ugolini G, Saur NM, et al. Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study. J Clin Oncol. 2023. PMID: 37390383. doi:10.1200/JCO.22.02195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。